-
Thematic Analysis
Scaling Rearmament – Thematic Intelligence
Reasons to buy the ‘Scaling Rearmament’ thematic intelligence report: Obtain in-depth insights into different rearmament efforts being undertaken by various military organizations and defense companies to understand the market better. Study the emerging trends and how they will influence the scaling rearmament theme and their broader impact on the defense market. Get an overview of the specific drivers of large-scale rearmament today, as well as the challenges that forces and defense sector suppliers face. Explore thematic investment opportunities for armed...
-
Sector Analysis
NewDental Scaling Units Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Dental Scaling Units Market Report Overview The Dental Scaling Units market size was valued at $292.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Scaling units are used to remove plaque, bacterial endotoxins, and calculus formed on teeth. Plaque bacteria, acids, and certain foods contribute to the development of calculus. Dental Scaling Units Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Dental Scaling Units...
-
Sector Analysis
NewSmall-Scale LNG (SSLNG) Liquefaction Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Projects and Forecast to 2028
Global small-scale liquefied natural gas (SSLNG) liquefaction capacity is expected to grow by 26% over the next four years, potentially increasing from 38,210 thousand tonnes per annum (ktpa) in 2024 to 47,960 ktpa in 2028. The growing importance of SSLNG for decarbonization of marine and road transport, and other applications such as off-grid power generation is driving such substantial growth.
-
Company Insights
NewAccelevir Diagnostics LLC Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Accelevir Diagnostics LLC Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Accelevir Diagnostics LLC is a biotechnology company specializing in the development of innovative assays for ultra-rare analytes in the field of infectious diseases and beyond. The company is involved in the creation, scaling, and commercialization of complex assay workflows. It is headquartered in Baltimore, Maryland, the US. GlobalData's Medical Devices company profile report, “Accelevir Diagnostics LLC Pipeline Insight and...
-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Sector Analysis
NewAustria Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Austria Defense Market Report Overview In 2024, Austria's defense budget is worth $4.3 billion and will grow at a CAGR of more than 5% during 2025-2029. Austrian defense spending, as with many other European nations, has seen an appreciable uptick as the crisis in continental security stemming from Russia’s full-scale invasion of Ukraine. Austria Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for More Insights into the Austria Defense Market Forecast Download a Free Report Sample The Austria...
-
Product Insights
NewQuadrant Biosciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Quadrant Biosciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Quadrant Biosciences Inc (Quadrant Biosciences) is a life science company that develops functional assessments and epigenetic diagnostic solutions for large-scale health issues and it has leveraged its expertise in RNA analysis to address the Covid-19 pandemic. Quadrant Biosciences is headquartered in Syracuse, New York, the US. GlobalData's Medical Devices company profile report, “Quadrant Biosciences Inc Pipeline Insight and Competitive...
-
Product Insights
NewProteomics International Laboratories Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Proteomics International Laboratories Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Proteomics International Laboratories Ltd (Proteomics) works as a medical technology organization that finds new biopharmaceutical drugs. It outfits its exclusive proteomics-based technology stage to work in three coordinated regions: diagnostics, logical services and medication revelation. Proteomics is the large-scale mapping of the structure and function of proteins. Proteomics created PromarkerD, a prescient test for the determination of diabetic...
-
Product Insights
NewAenitis Technologies Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Aenitis Technologies Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aenitis Technologies develops novel solutions for separation, handling and filtration of biological particles in suspension by using acoustic radiation forces. The company uses its patented acoustophoresis based approach that is applied to micro-scales for cells sorting. Aenitis Technologies develops a technology that utilizes the acoustic strength generated between the walls of a micro-channel in order to separate particles or cells....
-
Product Insights
NewGlaukos Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Glaukos Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such as microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma....